G
Gülsevim Azizlerli
Researcher at Istanbul University
Publications - 10
Citations - 1269
Gülsevim Azizlerli is an academic researcher from Istanbul University. The author has contributed to research in topics: Behcet's disease & Vascular disease. The author has an hindex of 8, co-authored 10 publications receiving 1169 citations.
Papers
More filters
Journal ArticleDOI
Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease
Elaine F. Remmers,Fulya Cosan,Yohei Kirino,Michael J. Ombrello,Neslihan Abaci,Colleen Satorius,Julie M. Le,Barbara Yang,Benjamin D. Korman,Aris Cakiris,Oznur Aglar,Zeliha Emrence,Hulya Azakli,Duran Ustek,Ilknur Tugal-Tutkun,Gulsen Akman-Demir,Wei-Wei Chen,Christopher I. Amos,Michael B. Dizon,Afet Akdag Kose,Gülsevim Azizlerli,Burak Erer,Oliver J. Brand,Virginia G. Kaklamani,Phaedon G. Kaklamanis,Eldad Ben-Chetrit,Miles Stanford,Farida Fortune,Marwen Ghabra,William E R Ollier,Young-Hun Cho,Dongsik Bang,John M O'Shea,Graham R. Wallace,Massimo Gadina,Daniel L. Kastner,Ahmet Gül +36 more
TL;DR: The known association of Behçet's disease with HLA-B*51 was confirmed and a second, independent association within the MHC Class I region was identified and the disease-associated IL10 variant was associated with diminished mRNA expression and low protein production.
Journal ArticleDOI
Prevalence of Behçet's disease in Istanbul, Turkey.
Gülsevim Azizlerli,Afet Akdag Kose,Rifkiye Sarica,Ahmet Gül,İlknur Tuğal Tutkun,Mustafa Kulaç,Recep Tunc,Meri Urgancioglu,Rian Disci +8 more
TL;DR: This data indicates that the prevalence of Behçet's disease is much higher in countries along the ancient Silk Route, extending from Japan to Mediterranean countries including Turkey, than in northern Europe and the USA.
Journal ArticleDOI
Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases.
Rifkiye Sarica-Kucukoglu,Afet Akdag-Kose,Murat Kayabali,Kurtuluş Didem Yazganoğlu,Rian Disci,Dilek Erzengin,Gülsevim Azizlerli +6 more
TL;DR: The aim of this study was to evaluate the prevalence and types of vascular involvement in Behçet's disease and to identify the most common types ofascular lesions.
Journal ArticleDOI
Interferon alfa-2a in the treatment of Behçet's disease.
TL;DR: Results indicate that interferon alfa-2a is a promising drug in the treatment of Behçet's disease and is particularly effective in skin manifestations such as genital ulceration and erythema-nodosum-like lesions.
Journal ArticleDOI
Juvenile Behçet's disease among 1784 Turkish Behçet's patients
TL;DR: This data indicates that Behçet's disease is a chronic, relapsing disease, about which information on its clinical course in juveniles is only available from small groups of patients.